Kyto Technology and Life Science Inc
OTC:KBPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kyto Technology and Life Science Inc
OTC:KBPH
|
US |
|
C
|
Cosigo Resources Ltd
OTC:COSRF
|
CA |
|
Sky Energy Indonesia Tbk PT
IDX:JSKY
|
ID |
|
A
|
Aubay SA
XBER:BAQ
|
FR |
|
Genius Electronic Optical Co Ltd
TWSE:3406
|
TW |
Balance Sheet
Balance Sheet Decomposition
Kyto Technology and Life Science Inc
Kyto Technology and Life Science Inc
Balance Sheet
Kyto Technology and Life Science Inc
| Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
7
|
|
| Total Assets |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
+21 136%
|
3
+70%
|
8
+212%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Current Liabilities |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
0
-83%
|
0
+42%
|
0
-89%
|
0
+216%
|
0
+71%
|
0
+44%
|
0
-91%
|
0
+11%
|
1
+4 374%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
|
| Retained Earnings |
18
|
18
|
18
|
32
|
32
|
32
|
32
|
33
|
33
|
33
|
|
| Additional Paid In Capital |
16
|
17
|
17
|
32
|
32
|
32
|
32
|
32
|
36
|
40
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2
N/A
|
0
+83%
|
0
-42%
|
0
+89%
|
0
-216%
|
0
-71%
|
0
-40%
|
2
N/A
|
3
+71%
|
7
+162%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
+21 136%
|
3
+70%
|
8
+212%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
3
|
3
|
3
|
3
|
6
|
6
|
10
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
4
|
|